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Abstract
Increasing popularities of bioactive-glasses and their potential medical applica-
tions have led to countless studies into improving their material characteristics and 
overall performance. Some scientists hope to create new bioactive-glass compositions, 
while others seek to merely modify existing ones such as the novel 45S5 bioactive-glass 
composition; created by Dr. Larry Hench. These modifications aim to address potential 
complications that may arise at a site following implantation such as bacterial infec-
tions. In other cases, the incorporation of a selected element or compound may aim to 
improve the implant functioning by increasing cell proliferation. Although possibilities 
are plentiful, researchers avoid compromising the typical bioactive glass characteristics 
when doping with elements such as silver, or gold to achieve additional properties. This 
chapter elaborates on the incorporation of popular elements by doping bioactive-glass 
compositions to introduce desired properties based on the implant application.
Keywords: doping, bioactive glass, hydroxyapatite, angiogenesis, osteogenesis, 
osteoconductive, biocompatibility, cell proliferation
1. Introduction
A bioactive material is one that is able to elicit a specific biological response at 
the interface of a material that results in bond formation between the body tissues 
and the material that they surround [1]. Common bioactive materials include bioac-
tive glasses, and from that derived bioactive glass-ceramics and bioactive ceramics.
Bioactive glass was first introduced in the late 1960’s by Dr. Larry Hench after an 
enlightening conversation with an army officer while attending a scientific confer-
ence. During their discussion, they connected on the common tragic injuries that 
the soldiers were experiencing during the Vietnam War that was occurring at that 
time. These types of injuries involved those to the limbs, and during that time, the 
treatment quite often involved amputation due to the absence of a material capable of 
effectively supporting the hands or the feet. Over the next few years, Hench and his 
students developed a soda-calcia-phosphate-silicate based glass composition, which 
was proven to stimulate bone [2]. The result of this development in 1969 was the 
well-known and copyrighted 45S5 Bioglass. This discovery was the beginning of a new 
generation of materials, acting as temporary substrates for supporting damaged tis-
sues [3], and since then launched products formed from variations of bioactive glasses 
and glass-cermaics such as calcium phosphates and synthetic hydroxyapatite [4–7].
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The main purpose of such substrates was to create implants that react to the 
body’s process unlike the implants that were in use at that time which were inert 
or unreactive. His continued study focused on revealing the mechanism on why 
his novel glass composition, 45S5, was able to interact with the body as a result of 
by-products from the dissolution of the glass components in the body [8, 9].
When a glass is designed to function as a potential implant and possess bioac-
tive features, its behavior is monitored as certain criteria must be achieved before 
confirming bioactivity. This can be done by determining its surface type. There 
are five surface type characteristics of silica-based glasses. Type I surfaces undergo 
only a thin surface layer hydration when exposed to the bodily aqueous environ-
ment. In a case like that, the bulk composition is similar to that of the surface 
composition. Type II surfaces consists of a silica-rich protective film that occurs as 
a result of selective alkali ion removal. Type III surfaces are known for their ability 
to form dual surface layers, known to contribute to durability in both acidic and 
alkali solutions. Type III surface interactions are characteristic of an ideal bioactive 
glass. Type IV surfaces have the ability to form a silica-rich layer, however, the silica 
concentration is not high enough to protect the glass from further attack by network 
dissolution. Therefore, they are known to have poor durability. Glasses that undergo 
congruent dissolution with equivalent loss of alkali and silica exhibit that of a Type 
V glass surface [10].
2. What constitutes an effective bioactive glass?
The original purpose for creating a bioactive glass was to form a chemical bond 
with bone, and this was achieved by Dr. Larry Hench as stated prior. It is important 
to understand the mechanism of how this interaction became possible. According 
to Hench, further thermodynamic studies allowed us to understand that there is a 
formation of an organic structure being derived from an inorganic one. He was able 
to determine that the stability of Bioglass® came as a direct result of the formation 
of a Type III surface [10]. This usually occurs as the result of the presence of phos-
phorus pentoxide P2O5 in its composition or in some cases, aluminum(III) oxide 
Al2O3, forming an additional surface layer of either alumina-silicate or calcium-
phosphate species on the surface of the silica-rich layer. This comes as a result of 
dealkalization, surface structural modifications or precipitation from solution [9, 
10]. Glasses like these tend to be very durable in both acidic and alkaline solutions, 
which contribute to the formation of a hydroxyapatite layer capable of creating a 
bond with tissue.
Hench, his students, and his second wife, June Wilson, a clinical biologist, also 
noted that this mechanism contributed to 45S5 creating strong bonds to living 
tissue because of the expression of bone-growth genes [2, 11] in the body that was 
stimulated by the chemical byproducts of the glass components in the body due to 
Type III surface interaction [10].
2.1  Mechanism of bioactive glass as an implant and hydroxyapatite (HA) 
formation
The chemical mechanism that occurs once a bioactive glass is successfully 
introduced into the body as an implant involves a series of ion transfer reactions, 
as shown in Figure 1, that result in the formation of hydroxyapatite (HA). The 
HA formation is required for the conformation of bioactivity. When a bioactive 
glass comes into contact with the bodily environment, a series of reactions occur to 
confirm bioactivity according to Figure 1 in a 5-stage process:
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1. Cation exchange involving the monovalent and bivalent cations present in the 
glass with the H+ from the solution, leading to the formation of Si-OH (silanol) 
bonds on the glass surface and an increase in pH.
2. The pH continues to increase while Si-O-Si bonds are attacked by hydroxyl 
ions, causing soluble silica Si(OH)4 to be lost in solution and increases the 
silanol concentration at the glass surface exposed to the fluid.
3. Condensation and polymerization of silanol groups occur, resulting in the 
formation of a silica-rich amorphous layer (silica gel).
4. Calcium and phosphate ions diffuse through the silica gel, forming and amor-
phous CaO-P2O5 rich film on the silica gel layer film which later crystalizes.
5. The crystallization of the CaO-P2O5 amorphous layer leads to the formation  
of HA.
Following the confirmation of bioactivity in stage 5, adsorption and desorption 
of growth factors, produced by the surrounding cells, are enhanced by the HA 
layers. Thereafter, macrophages prepare the implant site for tissue repair by the 
elimination of dead cells, followed by the attachment of osteoblast stem cells. The 
following stage involves the differentiation and proliferation of the osteoblast stem 
cells toward the mature osteoblast phenotype. This typically occurs within hours to 
weeks depending on the class of the bioactive material. Thereafter, generation of an 
extracellular matrix occurs as growth factors stimulate cell division and mitosis and 
Figure 1. 
Illustration of series of ion exchanges involved in the formation of HA [12].
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the proteins required for the matrix development. The extracellular matrix becomes 
mineralized followed by the encasement of mature osteocytes in a collagen-HCA 
matrix, resulting in bone growth [13].
2.2 The original Bioglass® composition
The novel glass composition Bioglass 45S5 was of the Na2O-CaO-SiO2-P2O5 glass 
system and was known to possess a high calcium concentration with its composi-
tion close to a eutectic in the Na2O-CaO-SiO2 phase diagram [4, 5, 14]. Hench’s 
novel discovery included this glass system in the following mol% concentration: 
46.1%SiO2, 24.4%Na2O, 26.9%CaO, 2.6%P2O5. This glass composition was trade-
marked Bioglass® and since then has only been used in Ref. to the 45S5 composition 
and not for any other general bioactive glasses [14]. Its ability to create a bond to 
bone so strong that it could only be removed once the bone was broken.
2.3 Characterization and measurement of bioactivity
Figure 2 illustrates a ternary plot in increments of 10 wt% of the three base 
compounds with the addition on P2O5 for the formation of the novel Bioglass® com-
position, and for the design of other potential bioactive glasses and glass ceramics 
based on the wt% of each component. Within it identifies regions of bonding type as 
it relates to the ability to bond to hard or soft tissue. This is a good tool to predict the 
bioactive behavior of glass compositions within the SiO2-Na2O-CaO series and other 
potential series depending on the compounds involved in the desired composition.
The index of bioactivity, IB, is used to indicate the measurement of the bioactiv-





, where t0.5bb is the time for 
more than 50% of the implant interface to be bonded to bone [16]. Bioactivity 
increases as the IB increases.
Since 1994, bioactive materials were classified into Class A and Class B types. 
Class A bioactive materials were determined to be osteoproductive materials which 
Figure 2. 
Compositional dependence (wt%) of bone bonding and soft tissue bonding of bioactive glass and glass-
ceramics. The compositions within region a have a constant 6%P2O5 apart from AW glass ceramic which 
consists of concentration of P2O5 greater than 6%. Regions S and E both have the ability to interact with 
and bond to soft tissue and within region E specifically lies the novel bioglass® composition reprinted with 
permission from [15].
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elicit both intracellular and extracellular responses at its interface. Therefore, Class 
A bioactive glasses have the ability to bond with both bone and soft tissue. Class B 
materials are known as osterconductive materials which elicit only an extracellular 
response at its interface. Therefore, osteoconductive implants provide a biocompat-
ible interface along which bone migrates. Bioglass® is both osteoproductive and 
osteoconductive and has an IB of 10 [17]. Region D in Figure 2 has an IB of 0 while 
there is an IB of 2 at region A, and it increases as the composition becomes more 
central on the ternary plot [18].
Experimental processes known to test for bioactivity include in vivo or in vitro 
studies. However, many scientists have performed in vitro studies such as Simulated 
Body Fluid (SBF) testing followed by Fourier Transform infrared spectroscopy 
(FTIR), Scanning electron microscopy (SEM), and X-ray diffraction (XRD). FTIR 
analysis is performed to detect the presence of HA formation by identifying and 
evaluating bond bending and stretching inherent to particular functional groups. 
XRD analysis is possible through the evaluation of phase analysis and identification 
of peaks absorbed at certain wavelengths, while SEM analysis is used to evaluate the 
morphology and microstructure of the HA formation. These are indicated in the 
following Figure 3 for the analysis of a bioactive glass composition S4-Z1 after sub-
mersion in SBF solution at room temperature for 3, 7, 14, and 21 days respectively.
3. Development throughout the years
As Hench’s introduction of the novel 45S5 Bioglass® to the medical and engi-
neering era became popular, it birthed future opportunities and advancements for 
Figure 3. 
(a) XRD analysis and identification of HA formation through starred peaks after glass composition S4-Z1 is 
immersed in SBF solution for 3,7, 14 and 21 days respectively. (b) FTIR analysis of S4-Z1 after immersion in 
SBF for 3. 7, 14, and 21 days respectively. (c) HA formation identified via SEM analysis after immersion in 
SBF solution for 21 days. Reprinted with permission [19].
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bioactive glasses as researchers sought to make targeted improvements with it to 
further their knowledge about their applications. Additionally, toxicity of the glasses 
and environmental factors such as temperature, pressure, and pH must be considered 
when designing a particular bioactive glass for medical applications. Throughout 
the years, bioactive glasses have been used in the following areas: dental fillings and 
treatment, scaffold production, incorporation into other materials such as polymers 
and for hard and soft bone tissue engineering [20]. Further exploration and experi-
mentation with bioactive glass compositions, led to the formation of many different 
compositions intended for specific purposes which were achieved by incorporating 
other compounds to customize them based of the desired characteristics. A few base 
compositions that have been created overtime is listed in the following Table 1.
Most of the bioactive glass compositions in Table 1 consists of the following four 
compounds: SiO2, Na2O, CaO, and P2O5. The original 45S5 composition served to 
identify which combinations of compounds produced a glass with ideal bioactive 
properties. While the S53P4 composition comprised of a slight variation of Hench’s 
original 45S5 composition, the 13-93 and 13-93B1 compositions include compounds 
not found in Hench’s original composition. Although these deviations from the 
45S5 composition reduces their bioactive potential, other benefits are gained. For 
example, S53P4 bioactive glass is more stable than the 45S5 composition and borate-
based bioactive glasses stimulate faster hydroxyapatite (HA) formation rates. 
Magnesium ions have been shown to increase bioactive glass antibacterial proper-
ties and synergize well with host Mg ions in the body during the bone formation 
process. Furthermore, the “addition of borate ions into the glass matrix has been 
proven to increase apatite formation rates” on bioactive glass surfaces. This in turn 
opens the potential for a faster bone remodeling process [21].
The continuous evolution of bioactive glasses is also revealed through their clini-
cal applications. Silica-base bioactive glasses such as the nominal 45S5 and the S53P4 
composition were the original accepted standard in the implantation industry. 
Their rapid surface reaction time and comparatively low softening temperatures 
allow for optimal conditions for bone remodeling. Recently, though, borate-based 
bioactive glasses have gained a foothold in the tissue engineering market. Having 
been approved in 2016 and 2018 respectively, the 13-93B3 and GL1605 compositions 
represent the newer borate bioactive glass compositions. Borate glasses on average 
have been shown to release Na and Ca ions at a faster rate than their silica-based 
counterparts [22]. They are also responsible for slower regional pH increases than 
silica glasses due to reduced concentrations of alkali ions and the presence of boron. 
Whether these features are improvements to silica-based glasses or not is up to 
researchers and their intended applications, but nevertheless, borate glasses have 
contributed to the expansion of the bioactive glass market.
Composition (wt%)
Name SiO2 Na2O CaO P2O5 K2O MgO B2O3 ZnO CuO Source
45S5 45.0 24.5 24.5 6.0 • • • • • [20]
S53P4 53.0 23.0 20.0 4.0 • • • • • [20]
13-93 53.0 6.0 20.0 4.0 12.0 5.0 • • • [20]
13-93B1 34.4 5.8 19.5 3.8 11.7 4.9 19.9 • • [20]
13-93B3 • 6.0 20.0 4.0 12.0 5.0 53.0 • • [22]
GL1605 • 6.4 20.0 4.0 12.0 5.0 51.6 1.0 0.4 [22]
Table 1. 
Composition of various silicate-based bioactive glasses [20].
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3.1 Limitations of bioactive glasses
Like all materials, researchers are continuously testing and expanding the 
limitations of the base bioactive compositions. For example, some base composi-
tions are more appropriate for environments under constant load while others for 
those of brief, high load amplitudes. Another factor to consider is the alkalinization 
of regions introduced to bioactive glasses. While this may not be significant at lower 
concentrations, it hinders the extent that base bioactive glass compositions can be 
incorporated into the body since large pH changes can be detrimental to human 
health. Researchers in response have to determine viable methods of retaining 
the beneficial effects bioactive glasses present while lessening their control over 
regional pH. Likewise, the intrinsic brittle nature of bioactive glasses has prompted 
researchers to consider alternative methods of incorporating them into the body 
that maintain their biological benefits while increasing their strain to failure nature 
[23–25]. Rather than diverting valuable resources toward synthesizing different 
base bioactive glass compositions for singular uses, researchers are now looking 
to expand base properties through a variety of methods. The goal is to synthesize 
inorganic bioactive glasses that feature similar properties to materials found within 
the human body (Table 2).
3.2 Doping-glass performance and manipulation
Customization and improvement of bioactive glasses can be achieved through 
doping. Doping involves the introduction of impurities or other elements into a 
base composition that would result in the enhancement in properties (mechani-
cal, biological, structural, thermal, electrical, optical) of the particular product. 
Wetzel et al indicated a limitation of Bioglass® where it easily crystalized during 
high temperature processing. They deduced that the addition of Mg or Zn on the 
form of MgO or ZnO even at low concentrations improved the thermal behavior 
of Bioglass® [24]. Although doping is relatively simple to accomplish, the doping 
technique implemented can affect the extent of doping taking place. Likewise, there 
are various parameters one must consider when doping a material or bioglass in 
this instance. As previously stated, a doping technique must be selected under the 
assumption that some techniques are more applicable under certain conditions than 
others. For example, the standard melting technique is relatively straightforward, 
but the P2O5 within the bioactive glass has a much lower melting temperature 
than the other components [24–26]. A higher temperature processing can lead to 
the evaporation of a portion of the substance composition, therefore decreasing 
the overall bioactive potential of the glass along with other properties. Moreover, 
















HA 35–120 60–120 100–150 0.8–1.2 90–140 Ceramic [20]
Bioglass® 45S5 60 40 • 0.6 • Glass [20]
Bioglass 52S4.6 60 40 • • • Glass [20]
Trabecular Bone 0.05–0.6 10–20 1.5–7.5 0.1–0.8 40–60 • [20]
Cortical Bone 7–30 50–150 100–135 2–12 60–75 • [20]
Table 2. 
Mechanical properties of various bioactive glasses, ceramics, and human bones [20].
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The CaO present in the Bioglass® composition increases its durability. Studies 
have shown that “when 10 mol% of CaO was substituted with 10 mol% SiO2 to form 
20%Na2O-10%CaO-70%SiO2”, it exhibited a slower Na
+ dissolution, and a more 
stabilized SiO2-rich surface film when compared to the binary 20%Na2O-80%SiO2. 
This is due to the presence of CaO acts as a modifier that increases the coupling 
reactions between Si-O-Si and NS bonds, stabilizing the SiO2 rich film by filling the 
micro voids that form as a result of the Na dissolution, satisfies the bond in this film 
and prevents any further loss of Na ions [10]. The presence of P2O5 allows for the 
formation of a secondary calcium phosphate film that develops on the side that is in 
contact with the organic fluid environment.
In some bioactive glass and dopant compositions, low dopant concentrations 
may not produce the desired properties while high concentrations can. On the other 
hand, high dopant concentrations may have disadvantages associated with them 
such as cytotoxic and carcinogenic effects while low concentrations minimize them 
and provide protection from these drawbacks. Additionally, the application that a 
bioactive glass will be used for must also be taken into account when doping.
Other functional variables such as load, fatigue, temperature, and the sub-
stances that a bioactive glass will experience in its application are essential in the 
selection of a desired bioactive glass composition. While a doped bioactive glass 
may function well under minimal stress at room temperature, its properties may 
not be ideal in its environment of use. Therefore, it is important to consider the 
dopant material, concentration, and its application to ensure the promotion of ideal 
properties and the minimization of those that are not wanted.
Transition metals currently make up a large proportion of suitable dopants due 
to the medical benefits they provide. Elements like iron (Fe), copper (Cu), magne-
sium (Mg), and zinc (Zn) that already play vital roles within the human body are 
the focus of these studies [21, 26–30]. Similar interest has also been directed toward 
the rare earth elements. Various elements like Gadolinium (Gd), Erbium (Er), and 
Holmium (Ho) that are extensively used in a wide range of medical treatments are 
attractive avenues for researchers to explore [31–33]. While these make up most 
target dopant materials, much work is needed to understand the effects that doping 
a bioactive glass with one of these compounds will have and their extent. Figure 4 
reveals the cytotoxic effects that various transition element doping oxides have on 
cell lines. While some compounds may increase desired bioactive glass components, 
their biocompatibility should also be assessed before wide-spread usage.
3.2.1 Boron oxide (B2O5)
It has been experimentally revealed that borate glass systems exhibit greater 
hydroxyapatite (HA) formation and dissolution rates than their silicate-based 
relatives (ex: 45S5, 13-19, S53P4). Furthermore, borate glasses have been used for 
healing applications by medical professionals due to the borate ions possessing 
inherent antibacterial capabilities. When bioactive glasses are doped with borate 
ions, there was a “gradual increase in surface apatite formation rates” with increased 
concentration. [34] Additionally, the antibacterial properties of borate doped glass 
composition increased with greater doping concentrations. This trend is repeated 
microstructurally as the glass transition temperature, Tg, decreases with increasing 
borate concentrations. Moreover, the glass stability factor and crystallization peak 
temperature, Tp, gradually increased with increasing borate concentrations before 
decreasing once a concentration threshold is surpassed. This pattern is mirrored 
in cell proliferation studies and antibacterial tests concerning borate-doped bioac-
tive glasses. Therefore, it is important for researchers to weigh the importance of 
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enhanced HA formation against decreased glass stability, cell proliferation, and 
antibacterial properties at greater borate concentrations. As with all materials, the 
conditions these bioactive glasses will be performing in will determine the impor-
tance researchers place on these material properties.
3.2.2 Copper (Cu)
Cu is another metallic ion that researchers have incorporated into bioactive glass 
matrices and scaffolds to increase biological performance. Researchers are drawn 
to it because of its positive effects on endothelial cells and blood vessel maturation. 
Cu is also an essential ion in the human body and plays a pivotal role in angiogen-
esis, so doping bioactive glasses with it serves to enhance these benefits [28, 29]. 
This is upheld in Cu-doped calcium phosphates and bioactive glass scaffolds that 
reveal enhanced angiogenesis and stimulated osteogenesis in Cu-doped bioactive 
glass scaffolds. The Cu2+ ion also possesses natural antibacterial properties and 
works in conjunction with the Ca2+ ions in BGs to increase this property. Cu-doped 
bioactive glasses and scaffolds have also been shown to increase the differentia-
tion levels of mesenchymal stem cells (MSCs) and act as catalyzing agents in 
endothelial cell proliferation. On the other hand, bioactive glasses and scaffolds 
doped with Cu are less suitable at elevated temperatures than their non-doped base 
compositions. This is due to Cu weakening the BG matrix when it is doped which 
leads to a decreased glass transition temperature, Tg. While this may not change the 
benefits doping bioactive glasses with Cu provides, it does limit the applications of 
Cu-doped bioactive glasses and scaffolds.
Figure 4. 
Cell viability of various transition metal oxides on A549 cells. Figure 1A and B Model the importance of 
researchers understanding the biological effects dopant compounds have on the human body. Cell viabilities 
below 70% are considered to be cytotoxic. While Cr2O3 and Fe2O3 caused little to no change in cellular viability, 
the same cannot be said for the oxides of Cu, Zn, Mn, and Ni. However, these ions are also key contributors to 
various vital functions in the human body [28].
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3.2.3 Gold (Au)
Bioactive glasses doped with gold nanoparticles (AuNPs) have also garnered 
interest among researchers. This is because AuNPs possess a wide range of biomedical 
applications like therapy, hygiene, diagnostics, and prevention. It is important to note 
that AuNPs with small diameters (1–2 nm) are toxic in the human body because they 
cause damage to cell structures when absorbed [35]. However, particle diameters from 
3 to 100 nm appear to not have any toxic effect on cellular structures. Not only does 
doping with AuNPs increase a BG’s biocompatibility, but they also increase the rate of 
the calcium phosphate layer on the surface, bettering its osteoconductive properties. 
Greater amplitudes in zeta potentials are also positively correlated with increasing 
dopant concentrations of AuNPs. In other words, increasing the dopant concentra-
tion of AuNP corresponds to greater long-term stability for the bioactive glasses. 
Interestingly, researchers have also discovered that AuNPs have the possibility of being 
released into nearby organs from the bioactive glasses they were doped with. This has 
led some to pursue methods of treatment delivery to specific regions of the body.
3.2.4 Iron (Fe)
Iron was one of the initial elements that were incorporated into bioactive glasses 
to increase their bioactivity and antibacterial properties [28]. Fe ions have been 
revealed to enhance the bone metabolism process which is why they were considered 
as potential doping candidates into bioactive glasses. Fe-doped bioactive glasses have 
characteristically lower crystallization temperatures than their non-doped counter-
parts and also have greater storage modulus values [27]. This is turn correlates to larger 
elastic modulus values for Fe-doped bioactive glasses, making them more suitable for 
implantation applications into the human body [25]. Likewise, scaffolds created from 
Fe-doped bioactive glasses have much greater degrees of formability than their base 
compositions. On the other hand, cytotoxic risks must be considered when doping with 
high concentrations of Fe which can have detrimental effects within patients and their 
environment. Interestingly, the magnetic properties present in Fe2+ ions are transferred 
into the base composition they are doped into. Researchers hope to take advantage of 
this magnetic behavior by expanding upon existing targeted therapeutic treatments.
3.2.5 Magnesium (Mg)
Magnesium is an important trace element in the human body, which is what 
makes it an excellent candidate for doping into bioactive glasses. The integral role 
Mg plays in bone development and maintenance drew researchers to include it 
among the first wave of transition metals to be considered as a suitable doping agent. 
Bioactive glasses doped with Mg have shown increased rates of HA formation on 
their surfaces and enhanced bioactive and antibacterial capabilities in comparison 
to their base concentrations [21]. Additionally, these bioactive glasses have exhibited 
superior long-term osteoconductive and biocompatibility properties. This is impor-
tant because researchers are continuously seeking methods to increase biomedical 
implant lifespans since the percentage of individuals outliving their implants is 
increasing. Furthermore, Mg-doped bioactive glasses have promising applications in 
skeletal tissue regeneration due to their lower ionic release rates which do not affect 
the cellular environment to the extent of those with elevated rates.
3.2.6 Rare earth elements (REE)
Many REE ions have practical medical applications including but not limited 
to imaging techniques, cancer treatments, and pain relief [32]. Therefore, it is not 
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surprising that some of these elements are viable options for therapeutic bioactive 
glasses. REE have been shown to promote bone repair and increase osteogenesis 
rates [31]. This is due to their ability to mimic calcium’s role in the bone repair 
process and open the door to bone density disorder treatments. There are concerns 
about their cytotoxicity to both patients and the environment (Table 3), but that 
is for researchers to determine what level of risk is acceptable while achieving 
sought-after results [33]. Furthermore, the sustainability of REE’s use as a whole is 
in question since demand for these naturally occurring elements will soon outweigh 
their supply. Solutions ranging from increased research into REE recycling and 
replacement are viable options to consider. However, one may also decide that the 
resources spent in developing a solution can be otherwise diverted to additional 
research into other dopant materials.
3.2.7 Silicon nitride (Si3N4)
Greater quantities of bone tissue around bioactive glasses have been observed 
with Si3N4-doped BGs [23]. This compound’s high strength, fracture toughness, low 
friction wear, and biocompatibility make it an ideal doping substance for bioactive 
glasses designed for load-bearing purposes. It is also important to note that Si3N4 is 
an osteoconductive biomaterial with the potential to catalyze osteogenesis. In other 
words, this compound increases the rate of bone formation by reducing the time 
it takes bone-forming cells to reach their target regions. Like other viable dopants, 
Si3N4 promotes MSC differentiation into osteoblasts and improves their adhe-
sion to organic material. This in turn leads to an increased production of collagen 
and mineralization, enhancing the bone formation process. The increased bone 
formation also corresponds with an increase in environment pH. This is due to the 
Na+ and Ca2+ ions being released during bone formation that create hydroxides 
which contribute to an increase in regional pH. This phenomenon is shared among 
most bioactive glass compositions, and there are a multitude of methods to negate 
potential detrimental effects to patients.
3.2.8 Silver (Ag)
Silver was one of the first transition metals that researchers attempted to dope 
bioactive glasses with. This is due to its inherent antibacterial capability that covers 
a wide array of diseases. Medical professionals have enjoyed its benefits in surgical 
applications and researchers sought to expand upon their success. It has been observed 
that Ag-doped bioactive glasses have greater bioactive and antibacterial capabilities 
than their non-doped bioactive glass counterparts [28]. Furthermore, Ag particles 
are able to diffuse uniformly throughout the bioactive glasses in which they are 
doped. The feature of not forming a separate Ag layer at the glass surface is important 
because some unintended and potentially dangerous cellular responses can occur [36]. 
Likewise, the antibacterial and bioactive benefits Ag particles present are coun-
tered by their possible cytotoxic effects in the human body at high concentrations. 
Therefore, researchers’ margin of error and the specific application of these bioactive 
glasses play key roles in determining the extent they are doped with Ag particles.
3.2.9 Zinc (Zn) and strontium (Sr)
Zinc and Strontium have been doped separately and together into bioactive 
glass compositions to optimize their properties. Zn is responsible for promoting 
bone formation while Sr. has been found to limit bone resorption and promote bone 
remodeling [30]. Bioactive glasses, MSC proliferation and differentiation processes 
Current Concepts in Dental Implantology - From Science to Clinical Research
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are also increased by the doping of Zn and Sr. When Zn is doped into the glass 
matrix, it is distributed uniformly, and the surface matrix experiences an acceler-
ated growth of its apatite layer. This in turn corresponds to an overall increase in 
bioactivity. It is important to note that doping the bioactive glass with too much 
Zn will increase the potential of cytotoxic effects and a create a lower degradation 
profile. Additionally, solely doping a bioactive glass with Sr. has been found to limit 
the formation of the apatite layer on the glass surface. Furthermore, the Sr-glass 
network is looser than the base glass and Zn-glass networks due to Sr’s ionic radius 
being larger than those of Ca, the element being substituted with the dopant mate-
rial, and Zn. Although extensive research has been done regarding these differences 
in glass networks, there do not seem to be any significant effects in BG properties 












Erbium (III) chloride 
hexahydrate
613.1 1135.2 31.6 0.0827 - 1.08 [33]
Lanthanum (III) 
chloride heptahydrate
379.4 962.6 28.2 0.076 - 1.12 [33]
Praseodymium (III) 
chloride hydrate
532.4 1085.1 18.7 0.0755 - 1.12 [33]
Europium (III) 
chloride hexahydrate
530.3 1078.4 26.9 0.0734 - 1.13 [33]
Gadolinium (III) 
chloride hexahydrate
571.2 1120.7 27.4 0.0736 - 1.13 [33]
Ytterbium (III) 
chloride hexahydrate
423.1 1001.3 31.0 0.0801 - 1.10 [33]
Samarium (III) 
chloride hexahydrate
575.6 1124.0 25.1 0.0689 - 1.16 [33]
Thulium (III) chloride 
anhydrous
440.7 1015.0 22.7 0.0825 - 1.08 [33]
Dysprosium (III) 
chloride hexahydrate
931.8 1264.0 31.5 0.0836 - 1.08 [33]
Terbium (III) chloride 
hexahydrate
397.4 979.2 31.6 0.0846 - 1.07 [33]
Holmium (III) 
chloride hexahydrate
963.6 1205.3 27.1 0.0714 - 1.15 [33]
Lutetium (III) chloride 
hexahydrate
580.2 1066.5 34.3 0.088 - 1.06 [33]
Yttrium (III) chloride 
hexahydrate
377.0 959.6 31.0 0.0801 - 1.10 [33]
Neodymium (III) 
chloride hexahydrate
418.5 966.2 25.8 0.072 - 1.14 [33]
Cerium (III) chloride 
heptahydrate
501.9 1067.1 31.7 0.0852 - 1.07 [33]
Barium Chloride 661.5 1184.0 15.6 0.075 - 1.12 [33]
Cadmium chloride 0.252 62.7 16.5 0.09 - 1.05 [33]
Table 3. 
Cytotoxicity and Ecotoxicity of rare earth compounds [33].
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when low doping concentrations are used. Likewise, it has been experimentally 
determined that small molar concentrations of Zn (~2%) and Sr. (~5%) produce 
optimum cell proliferation and differentiation properties, minimizing negative 
effects associated with elevated doping concentrations. Co-doping the bioactive 
glass composition with both Zn and Sr. results in a combination of the two dopant 
effects. The (Zn + Sr)-glass network promotes cell proliferation and differentiation 
while also limiting the formation of the glass’s surface apatite formation and bone 
resorption. These represent a few of the various elements and their effects that are 
considered throughout the glass doping process.
4. Conclusion
Over the past few decades, since the discovery of Bioglass® in 1969, hundreds 
of other bioactive glass compositions have been derived or attempted, all with the 
hopes of either improving properties of existing applications such as metal implants, 
or to personalize a specific composition for a unique application. For instance, using 
a bioactive glass composition to coat a particular metal alloy for implantation. Over 
the years, researchers have introduced elements in the form of compounds into base 
compositions with the aim of achieving distinct properties such as increased bio-
activity, anti-bacterial behavior, bone proliferation, etc. Therefore, they have since 
seen promising outcome when incorporating elements such as magnesium, copper, 
zinc, boron, and strontium, just to name a few. The evolution of bioactive glasses 
has already shown promising progress and is expected to be become a staple prat 
in medical devices and applications within the near future. However, this journey 
has yet to continue. It is important to evaluate the biological response to the newly 
developed bioactive glass compositions to fully understand their risks and benefits. 
We are curious to see where this field is leading us in the next years.
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